Dulcie B. Schmidt

3.0k total citations
55 papers, 2.4k citations indexed

About

Dulcie B. Schmidt is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Dulcie B. Schmidt has authored 55 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 15 papers in Oncology and 15 papers in Immunology. Recurrent topics in Dulcie B. Schmidt's work include Chemokine receptors and signaling (14 papers), Receptor Mechanisms and Signaling (14 papers) and Chemical Synthesis and Analysis (10 papers). Dulcie B. Schmidt is often cited by papers focused on Chemokine receptors and signaling (14 papers), Receptor Mechanisms and Signaling (14 papers) and Chemical Synthesis and Analysis (10 papers). Dulcie B. Schmidt collaborates with scholars based in United States, United Kingdom and Italy. Dulcie B. Schmidt's co-authors include Henry M. Sarau, James J. Foley, Douglas W.P. Hay, Peter T. Buckley, Nabil A. Elshourbagy, Frank C. Barone, Robert S. Ames, Giuseppe Giardina, John R. White and Parvathi Nuthulaganti and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Stroke.

In The Last Decade

Dulcie B. Schmidt

55 papers receiving 2.3k citations

Peers

Countries citing papers authored by Dulcie B. Schmidt

Since Specialization

Citations

This map shows the geographic impact of Dulcie B. Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dulcie B. Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dulcie B. Schmidt more than expected).

Fields of papers citing papers by Dulcie B. Schmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dulcie B. Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dulcie B. Schmidt. The network helps show where Dulcie B. Schmidt may publish in the future.

Co-authorship network of co-authors of Dulcie B. Schmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Dulcie B. Schmidt. A scholar is included among the top collaborators of Dulcie B. Schmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dulcie B. Schmidt. Dulcie B. Schmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacological Characterization of GSK573719 (Umeclidinium): A Novel, Long-Acting, Inhaled Antagonist of the Muscarinic Cholinergic Receptors for Treatment of Pulmonary Diseases 2013 ·Journal of Pharmacology and Experimental Therapeutics ·M Salmon, Mark A. Luttmann, James J. Foley, Peter T. Buckley, Dulcie B. Schmidt, Miriam Burman, Edward F. Webb, (unknown), Charles J. Kotzer, Victoria J. Barrett, Robert J. Slack, Henry M. Sarau, Michael R. Palovich, Dramane I. Lainé, Douglas W.P. Hay, William L. Rumsey	64
2	Tyrosine urea muscarinic acetylcholine receptor antagonists: Achiral quaternary ammonium groups 2012 ·Bioorganic & Medicinal Chemistry Letters ·Qi Jin, (unknown), (unknown), Jian Jin, Yonghui Wang, Katherine L. Widdowson, Michael R. Palovich, James J. Foley, Dulcie B. Schmidt, Peter T. Buckley, Edward F. Webb, M Salmon, Kristen E. Belmonte, Henry M. Sarau, Jakob Busch‐Petersen	3
3	Discovery of (3-endo)-3-(2-cyano-2,2-diphenylethyl)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane bromide as an efficacious inhaled muscarinic acetylcholine receptor antagonist for the treatment of COPD 2009 ·Bioorganic & Medicinal Chemistry Letters ·Zehong Wan, Dramane I. Lainé, Hongxing Yan, (unknown), Katherine L. Widdowson, Peter T. Buckley, Miriam Burman, James J. Foley, Henry M. Sarau, Dulcie B. Schmidt, Edward F. Webb, Kristen E. Belmonte, Michael R. Palovich	2
4	Optimized procedures for producing biologically active chemokines 2009 ·Protein Expression and Purification ·Quinn Lu, (unknown), Patrick McDevitt, (unknown), (unknown), James A. Fornwald, Xiaoyan Tang, Kathleen T. Gallagher, (unknown), James J. Foley, Dulcie B. Schmidt, (unknown), (unknown), Robert S. Ames, Kyung Johanson	15
5	Akute bakterielle Sakroiliitis durch Salmonella cholerae-suis 2008 ·DMW - Deutsche Medizinische Wochenschrift ·Dulcie B. Schmidt, Rémy Meier, P. E. Ochsner, W. Zimmerli, K. Gyr	2
6	N,N′-Diarylcyanoguanidines as antagonists of the CXCR2 and CXCR1 chemokine receptors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Hong Nie, Katherine L. Widdowson, Michael R. Palovich, (unknown), John D. Elliott, Deborah Bryan, Miriam Burman, Dulcie B. Schmidt, James J. Foley, Henry M. Sarau, Jakob Busch‐Petersen	21
7	The peptidic urotensin‐II receptor ligand GSK248451 possesses less intrinsic activity than the low‐efficacy partial agonists SB‐710411 and urantide in native mammalian tissues and recombinant cell systems 2006 ·British Journal of Pharmacology ·David J. Behm, Gerald P. Stankus, Christopher Doe, Robert N. Willette, Henry M. Sarau, James J. Foley, Dulcie B. Schmidt, Parvathi Nuthulaganti, James A. Fornwald, Robert S. Ames, David G. Lambert, Girolamo Calò, Valeria Camarda, Nambi Aiyar, Stephen A. Douglas	32
8	Comparison of N,N′-diarylsquaramides and N,N′-diarylureas as antagonists of the CXCR2 chemokine receptor 2006 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Michael R. Palovich, Katherine L. Widdowson, (unknown), Miriam Burman, James J. Foley, Dulcie B. Schmidt, Henry M. Sarau, Martin Rogers, Kevin L. Salyers, Peter D. Gorycki, Theresa J. Roethke, (unknown), Leonard M. Azzarano, Keith W. Ward, Jakob Busch‐Petersen	32
9	Identification, Molecular Cloning, Expression, and Characterization of a Cysteinyl Leukotriene Receptor 1999 ·Molecular Pharmacology ·Henry M. Sarau, Robert S. Ames, Jon Chambers, Catherine Ellis, Nabil A. Elshourbagy, James J. Foley, Dulcie B. Schmidt, Roseanna M. Muccitelli, Owen Jenkins, Paul R. Murdock, Nicole C. Herrity, Wendy S. Halsey, Ganesh M. Sathe, Alison I. Muir, Parvathi Nuthulaganti, George Dytko, Peter T. Buckley, Shelagh Wilson, Derk J. Bergsma, Douglas W.P. Hay	12
10	Identification, Molecular Cloning, Expression, and Characterization of a Cysteinyl Leukotriene Receptor 1999 ·Molecular Pharmacology ·Henry M. Sarau, Robert S. Ames, Jon Chambers, Catherine Ellis, Nabil A. Elshourbagy, James J. Foley, Dulcie B. Schmidt, Roseanna M. Muccitelli, Owen Jenkins, Paul R. Murdock, Nicole C. Herrity, Wendy S. Halsey, Ganesh M. Sathe, Alison I. Muir, Parvathi Nuthulaganti, George Dytko, Peter T. Buckley, Shelagh Wilson, Derk J. Bergsma, Douglas W.P. Hay	286
11	Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonists 1999 ·Il Farmaco ·Giuseppe Giardina, Marco Artico, (unknown), Alberto Cerri, (unknown), Stefania Gagliardi, (unknown), Mario Grugni, Douglas W.P. Hay, Mark A. Luttmann, (unknown), Luca F. Raveglia, (unknown), Henry M. Sarau, Dulcie B. Schmidt, (unknown), C Farina	18
12	In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4receptor antagonist with anti-inflammatory activity 1999 ·Prostaglandins Leukotrienes and Essential Fatty Acids ·Henry M. Sarau, James J. Foley, Dulcie B. Schmidt, Lenox D. Martin, Edward F. Webb, Maritsa N. Tzimas, John Breton, Marie Chabot‐Fletcher, David C. Underwood, Douglas W.P. Hay, William D. Kingsbury, Pamela A. Chambers, Israil Pendrak, Dalia R. Jakas, Ganesh M. Sathe, (unknown), R. A. DAINES, (unknown)	6
13	Cloning, in Vitro Expression, and Functional Characterization of a Novel Human CC Chemokine of the Monocyte Chemotactic Protein (MCP) Family (MCP-4) That Binds and Signals through the CC Chemokine Receptor 2B 1997 ·Journal of Biological Chemistry ·Theo A. Berkhout, Henry M. Sarau, Kitty Moores, John R. White, Nabil A. Elshourbagy, Edward R. Appelbaum, (unknown), (unknown), (unknown), James J. Foley, Dulcie B. Schmidt, (unknown), Dean E. McNulty, (unknown), Kevin O’Donnell, Daniel J. O’Shannessy, Miller O. Scott, Pieter H.E. Groot, Colin H. Macphee	88
14	Time-related changes in myeloperoxidase activity and leukotriene B4 receptor binding reflect leukocyte influx in cerebral focal stroke 1995 ·Molecular and Chemical Neuropathology ·Frank C. Barone, Leonard M. Hillegass, Maritsa N. Tzimas, Dulcie B. Schmidt, James J. Foley, R. F. White, William J. Price, G Feuerstein, Robert Clark, D.E. Griswold, Henry M. Sarau	95
15	Effects of scalaradial, a novel inhibitor of 14 kDa phospholipase A2, on human neutrophil function 1994 ·Biochemical Pharmacology ·(unknown), (unknown), Lisa A. Marshall, James J. Foley, Dulcie B. Schmidt, Henry M. Sarau	31
16	Synthesis of structural analogs of leukotriene B4 and their receptor binding activity 1993 ·Journal of Medicinal Chemistry ·William D. Kingsbury, Israil Pendrak, Jack D. Leber, Jeffrey C. Boehm, (unknown), Henry M. Sarau, (unknown), Dulcie B. Schmidt, R. A. DAINES	12
17	Trisubstituted pyridine leukotriene B4 receptor antagonists: synthesis and structure-activity relationships 1993 ·Journal of Medicinal Chemistry ·R. A. DAINES, Pamela A. Chambers, Israil Pendrak, Dalia R. Jakas, Henry M. Sarau, James J. Foley, Dulcie B. Schmidt, William D. Kingsbury	10
18	15-acetylthioxy-furodysinin lactone, isolated from a marine sponge , SP. is a potent agonist to human leukotriene B4 receptor 1990 ·Prostaglandins ·Seymour Mong, Bartholomew J. Votta, Henry M. Sarau, (unknown), Dulcie B. Schmidt, Brad Carté, (unknown), John Westley	6
19	Vasopressin receptor antagonism in rhesus monkey and man: stereochemical requirements 1989 ·European Journal of Pharmacology ·David P. Brooks, Paul F. Koster, Christine R. Albrightson, William F. Huffman, M. Lane Moore, F L Stassen, Dulcie B. Schmidt, Lewis B. Kinter	7
20	Potent vasopressin antagonist modified at the carboxy-terminal tripeptide tail 1987 ·Journal of Medicinal Chemistry ·Fadia E. Ali, (unknown), William F. Huffman, (unknown), Lewis B. Kinter, Edwin F. Weidley, (unknown), Dulcie B. Schmidt, (unknown), F L Stassen	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact